GSK plc (GSK) Latest News

NYSE Currency in USD Disclaimer

Add to Alerts ADD TO LIST

$39.66

$0.22 (0.56%)

Last update: 04:00 PM EST

Day's range

$39.21

$39.69

Latest News of GSK

MHRA approves GSK's oral antibiotic for UTIs in females

MHRA approves GSK's oral antibiotic for UTIs in females

By Yahoo! Finance | 3 days ago

Eli Lilly and GSK drive South Korea's drug licensing activity

Eli Lilly and GSK drive South Korea's drug licensing activity

By Yahoo! Finance | 2 weeks ago

GSK climbs after winning FDA priority review for oral gonorrhoea antibiotic

GSK climbs after winning FDA priority review for oral gonorrhoea antibiotic

By Yahoo! Finance | 3 weeks ago

GSK's world-first gonorrhoea vaccine launched in England

GSK's world-first gonorrhoea vaccine launched in England

By Yahoo! Finance | 3 weeks ago

GSK Lifts Outlook As Specialty Medicines, Vaccines Fuel Growth

GSK Lifts Outlook As Specialty Medicines, Vaccines Fuel Growth

By Yahoo! Finance | 1 month ago

GSK's speciality medicines soar while generals drop, Q2 results reveal

GSK's speciality medicines soar while generals drop, Q2 results reveal

By Yahoo! Finance | 1 month ago

China Market Update: Health Care Surges On Hengrui-GSK Deal, Market Cheers US-EU Trade Agreement

China Market Update: Health Care Surges On Hengrui-GSK Deal, Market Cheers US-EU Trade Agreement

By Forbes | 1 month ago

Hengrui Pharma and GSK link across key therapeutic areas

Hengrui Pharma and GSK link across key therapeutic areas

By Yahoo! Finance | 1 month ago

GSK's Blenrep combos approved for multiple myeloma in EU

GSK's Blenrep combos approved for multiple myeloma in EU

By Yahoo! Finance | 1 month ago

BofA Maintains a Sell Rating on GSK plc (GSK), Sets a PT of p1,510

BofA Maintains a Sell Rating on GSK plc (GSK), Sets a PT of p1,510

By Yahoo! Finance | 1 month ago

GSK's Blenrep faces setback as FDA cancer committee votes against approval

GSK's Blenrep faces setback as FDA cancer committee votes against approval

By Yahoo! Finance | 1 month ago

FDA Advisory Panel Votes Against Approval of GSK's Blenrep Combo

FDA Advisory Panel Votes Against Approval of GSK's Blenrep Combo

By Yahoo! Finance | 1 month ago

GSK's Blood Cancer Drug Faces US Setback Due To FDA Panel's Eye Safety Warning

GSK's Blood Cancer Drug Faces US Setback Due To FDA Panel's Eye Safety Warning

By Yahoo! Finance | 1 month ago

FDA approves GSK's prefilled syringe presentation of Shingrix

FDA approves GSK's prefilled syringe presentation of Shingrix

By Yahoo! Finance | 1 month ago

GSK shares fall after blood cancer drug likely headed for U.S. rejection

GSK shares fall after blood cancer drug likely headed for U.S. rejection

By Yahoo! Finance | 1 month ago